SIGNALING OF THE FRACTALKINE RECEPTOR CX3CR1 AND ITS NATURAL GENETIC VARIANTS: IMPACT OF RECEPTOR NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS

被引：0
|
作者：
Garcia-Silva, A. [1 ]
de la Fuente, R. A. [1 ]
Izquierdo, A. G. [1 ]
Loza, M. I. [1 ]
Costas, J. [2 ]
Castro, M. [1 ]
机构：
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela 15782, Spain
[2] Complexo Hosp Univ Santiago de Compostela CHUS, Inst Invest Sanitaria IDIS Santiago de Compostela, Serv Galego Saude SERGAS, Santiago De Compostela, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2017年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P-76
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] TRANSLOCATION OF BETA-ARRESTIN II BY FRACTALKINE AT CX3CR1 RECEPTORS: IMPACT OF RECEPTOR NON-SYNONYMOUS SINGLE NUCLEOTIDE POLYMORPHISMS (NSSNPS)
    Gonzalez-Izquierdo, A.
    de la Fuente-Gonzalez, R. A.
    Atanes-Juiz, P.
    Rodriguez-Carracedo, J.
    Dominguez-Medina, E.
    Loza-Garcia, M., I
    Costas-Costas, J.
    Castro-Perez, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 40 - 40
  • [2] Association of Common Polymorphisms in the Fractalkine Receptor (CX3CR1) With Obesity
    Sirois-Gagnon, Dave
    Chamberland, Annie
    Perron, Stephanie
    Brisson, Diane
    Gaudet, Daniel
    Laprise, Catherine
    OBESITY, 2011, 19 (01) : 222 - 227
  • [3] Fractalkine and its receptor, CX3CR1, expression in diabetic kidneys.
    Kikuchi, Y
    Suzuki, S
    Ikee, R
    Hemmi, N
    Hyodo, N
    Saigusa, T
    Namikoshi, T
    Yamada, M
    Miura, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 601A - 601A
  • [4] A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection
    Robinson, LA
    Nataraj, C
    Thomas, DW
    Howell, DN
    Griffiths, R
    Bautch, V
    Patel, DD
    Feng, LL
    Coffman, TM
    JOURNAL OF IMMUNOLOGY, 2000, 165 (11): : 6067 - 6072
  • [5] Fractalkine and its receptor CX3CR1 are upregulated in inflammatory bowel disease
    Kobayashi, Taku
    Okamoto, Susumu
    Iwakami, Yuko
    Nakazawa, Atsushi
    Hisamatsu, Tadakazu
    Imai, Toshio
    Hibi, Toshfumi
    GASTROENTEROLOGY, 2006, 130 (04) : A355 - A355
  • [6] The fractalkine receptor CX3CR1 is a key mediator of atherogenesis
    Cybulsky, MI
    Hegele, RA
    JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08): : 1118 - 1120
  • [7] Molecular cloning and characterization of canine fractalkine and its receptor CX3CR1
    Maeda, Shingo
    Ohno, Koichi
    Nakashima, Ko
    Fukushima, Kenjiro
    Tsukamoto, Atsushi
    Suzuki, Hiyoshi
    Fujiwara, Aki
    Goto-Koshino, Yuko
    Fujino, Yasuhito
    Tsujimoto, Hajime
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2012, 145 (1-2) : 100 - 109
  • [8] Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1 - A genetic risk factor
    Ghilardi, G
    Biondi, ML
    Turri, O
    Guagnellini, E
    Scorza, R
    STROKE, 2004, 35 (06) : 1276 - 1279
  • [9] Role of fractalkine/CX3CL1 and its receptor CX3CR1 in allergic diseases
    Julia, Valerie
    Staumont-Salle, Delphine
    Dombrowicz, David
    M S-MEDECINE SCIENCES, 2016, 32 (03): : 260 - 266
  • [10] Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients
    Dimberg, Jan
    Dienus, Olaf
    Lofgren, Sture
    Hugander, Anders
    Wagsater, Dick
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2007, 22 (10) : 1195 - 1200
12345